{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Newport+East&answer.answeringMemberConstituency=Rochester+and+Strood&hansardHeading=Avara+Avlon+Pharma+Services%3A+Insolvency", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberConstituency=Newport+East&answer.answeringMemberConstituency=Rochester+and+Strood&hansardHeading=Avara+Avlon+Pharma+Services%3A+Insolvency", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Newport+East&answer.answeringMemberConstituency=Rochester+and+Strood&_metadata=all&hansardHeading=Avara+Avlon+Pharma+Services%3A+Insolvency", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&tablingMemberConstituency=Newport+East&answer.answeringMemberConstituency=Rochester+and+Strood&hansardHeading=Avara+Avlon+Pharma+Services%3A+Insolvency", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Newport+East&answer.answeringMemberConstituency=Rochester+and+Strood&hansardHeading=Avara+Avlon+Pharma+Services%3A+Insolvency", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Newport+East&answer.answeringMemberConstituency=Rochester+and+Strood&hansardHeading=Avara+Avlon+Pharma+Services%3A+Insolvency", "items" : [{"_about" : "http://data.parliament.uk/resources/1139700", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139700/answer", "answerText" : {"_value" : "<p>My rt. hon. Friend the Secretary of State has had no discussions with Avara. This is a commercial matter which BEIS have been monitoring for some time, however we have not sought to intervene while staff consultation and the administration process are underway.<\/p><p> <\/p><p>AstraZeneca announced on Wednesday that they have set aside funding of up to £12m, to be administered independently, to make sure their former employees at the Avlon site receive full severance should the ongoing administration of the site not generate enough funds to cover redundancy costs.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4487", "label" : {"_value" : "Biography information for Kelly Tolhurst"}
        }
        , "answeringMemberConstituency" : {"_value" : "Rochester and Strood"}
        , "answeringMemberPrinted" : {"_value" : "Kelly Tolhurst"}
        , "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-22T16:50:37.263Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2019-07-17", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Avara Avlon Pharma Services: Insolvency"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with Astrazeneca and Avara Avlon about the (a) three year guarantee on enhanced redundancy payments and terms for staff agreed as part of the sale of the company for £1 in December 2016 and the (b) collapse of Avara Avalon.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1548", "label" : {"_value" : "Biography information for Jessica Morden"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newport East"}
      , "tablingMemberPrinted" : [{"_value" : "Jessica Morden"}
      ], "uin" : "278449"}
    , {"_about" : "http://data.parliament.uk/resources/1139408", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139408/answer", "answerText" : {"_value" : "<p>My rt. hon. Friend the Secretary of State has had no discussions with AstraZeneca. This is a commercial matter which BEIS have been monitoring for some time, however we have not sought to intervene while staff consultation and the administration process are underway.<\/p><p> <\/p><p>AstraZeneca announced yesterday that they have set aside funding of up to £12m, to be administered independently, to make sure their former employees at the Avlon site receive full severance should the ongoing administration of the site not generate enough funds to cover redundancy costs.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4487", "label" : {"_value" : "Biography information for Kelly Tolhurst"}
        }
        , "answeringMemberConstituency" : {"_value" : "Rochester and Strood"}
        , "answeringMemberPrinted" : {"_value" : "Kelly Tolhurst"}
        , "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-22T17:01:48.157Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Avara Avlon Pharma Services: Insolvency"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with AstraZeneca about the collapse of Avara Avlon and enhanced redundancy pay for employees.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1548", "label" : {"_value" : "Biography information for Jessica Morden"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newport East"}
      , "tablingMemberPrinted" : [{"_value" : "Jessica Morden"}
      ], "uin" : "277691"}
    , {"_about" : "http://data.parliament.uk/resources/1139410", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139410/answer", "answerText" : {"_value" : "<p>My rt. hon. Friend the Secretary of State has had no discussions with Avara. This is a commercial matter which BEIS have been monitoring for some time, however we have not sought to intervene while staff consultation and the administration process are underway.<\/p><p> <\/p><p>AstraZeneca announced yesterday that they have set aside funding of up to £12m, to be administered independently, to make sure their former employees at the Avlon site receive full severance should the ongoing administration of the site not generate enough funds to cover redundancy costs.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4487", "label" : {"_value" : "Biography information for Kelly Tolhurst"}
        }
        , "answeringMemberConstituency" : {"_value" : "Rochester and Strood"}
        , "answeringMemberPrinted" : {"_value" : "Kelly Tolhurst"}
        , "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-22T17:02:17.75Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Avara Avlon Pharma Services: Insolvency"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with Avara about the collapse of Avara Avlon and the enhanced redundancy pay for employees.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1548", "label" : {"_value" : "Biography information for Jessica Morden"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newport East"}
      , "tablingMemberPrinted" : [{"_value" : "Jessica Morden"}
      ], "uin" : "277692"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}